JP Morgan Chase
MEDP icon

JP Morgan Chase’s Medpace MEDP Stock Holding History

JP Morgan Chase’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115M Buy
214,912
+61,306
+40% +$28.3M 0.01% 993
2026
Q1 		$70.7M Buy
153,606
+17,623
+13% +$9.02M ﹤0.01% 1171
2025
Q4 		$76.4M Sell
135,983
-41,870
-24% -$23.8M ﹤0.01% 1089
2025
Q3 		$91.4M Sell
177,853
-87,417
-33% -$38.2M 0.01% 1042
2025
Q2 		$83.3M Buy
265,270
+117,301
+79% +$35.2M 0.01% 1031
2025
Q1 		$45.1M Buy
147,969
+803
+0.5% +$270K ﹤0.01% 1365
2024
Q4 		$48.9M Sell
147,166
-28,073
-16% -$9.52M ﹤0.01% 1344
2024
Q3 		$58.5M Buy
175,239
+12,455
+8% +$4.73M ﹤0.01% 1226
2024
Q2 		$67M Sell
162,784
-10,901
-6% -$4.32M 0.01% 1103
2024
Q1 		$70.2M Buy
173,685
+13,767
+9% +$4.84M 0.01% 1115
2023
Q4 		$49M Buy
159,918
+38,334
+32% +$10.3M ﹤0.01% 1228
2023
Q3 		$29.4M Sell
121,584
-4,273
-3% -$1.09M ﹤0.01% 1399
2023
Q2 		$30.2M Buy
125,857
+14,987
+14% +$3.11M ﹤0.01% 1400
2023
Q1 		$20.8M Buy
110,870
+10,518
+10% +$2.18M ﹤0.01% 1630
2022
Q4 		$21.3M Sell
100,352
-4,702
-4% -$939K ﹤0.01% 1622
2022
Q3 		$16.5M Sell
105,054
-5,080
-5% -$811K ﹤0.01% 1720
2022
Q2 		$16.5M Sell
110,134
-7,674
-7% -$1.11M ﹤0.01% 1763
2022
Q1 		$19.3M Buy
117,808
+10,632
+10% +$1.75M ﹤0.01% 1790
2021
Q4 		$23.3M Buy
107,176
+11,808
+12% +$2.47M ﹤0.01% 1696
2021
Q3 		$18.1M Sell
95,368
-23,324
-20% -$4.25M ﹤0.01% 1852
2021
Q2 		$21M Buy
118,692
+5,148
+5% +$888K ﹤0.01% 1797
2021
Q1 		$18.6M Buy
113,544
+22,828
+25% +$3.49M ﹤0.01% 1818
2020
Q4 		$12.6M Sell
90,716
-47,814
-35% -$6.03M ﹤0.01% 2016
2020
Q3 		$15.4M Buy
138,530
+65,507
+90% +$7.57M ﹤0.01% 1687
2020
Q2 		$6.79M Sell
73,023
-64,421
-47% -$5.48M ﹤0.01% 2221
2020
Q1 		$10.1M Sell
137,444
-22,221
-14% -$1.93M ﹤0.01% 1737
2019
Q4 		$13.4M Buy
159,665
+15,788
+11% +$1.22M ﹤0.01% 1878
2019
Q3 		$12.1M Buy
143,877
+26,266
+22% +$1.98M ﹤0.01% 1980
2019
Q2 		$7.54M Sell
117,611
-3,716
-3% -$214K ﹤0.01% 2317
2019
Q1 		$7.15M Sell
121,327
-7,736
-6% -$462K ﹤0.01% 2317
2018
Q4 		$6.83M Sell
129,063
-5,557
-4% -$305K ﹤0.01% 2316
2018
Q3 		$8.06M Buy
134,620
+28,849
+27% +$1.58M ﹤0.01% 2378
2018
Q2 		$4.55M Buy
105,771
+60,524
+134% +$2.44M ﹤0.01% 2762
2018
Q1 		$1.58M Sell
45,247
-48,692
-52% -$1.78M ﹤0.01% 3414
2017
Q4 		$3.41M Buy
93,939
+93,739
+46,870% +$3.29M ﹤0.01% 2978
2017
Q3 		$6K Buy
+200
New +$6.11K ﹤0.01% 4780
2017
Q1 		– Sell
-48,600
Closed -$1.75M – 5160
2016
Q4 		$1.75M Sell
48,600
-55,675
-53% -$1.85M ﹤0.01% 3149
2016
Q3 		$3.11M Buy
+104,275
New +$3.04M ﹤0.01% 2537

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase's MEDP Position: Q2 2026 in Review

JP Morgan Chase increased its Medpace (MEDP) stake by 40% in Q2 2026, buying an estimated $28.3M and bringing the position to 214,912 shares worth $115M. The position accounts for 0.01% of the portfolio, ranked #993.

JP Morgan Chase first reported a position in MEDP in Q3 2016 and has held it in 38 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • JP Morgan Chase held 214,912 shares of Medpace worth $115M as of Q2 2026.
  • JP Morgan Chase bought 61,306 Medpace shares in Q2 2026, an estimated $28.3M.
  • Medpace made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #993 holding.
  • JP Morgan Chase first reported a position in Medpace in Q3 2016 and has held it in 38 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.